TRICHOME PHARMA SL
Company details
- Active NIF/CIF: B02725604
-
-
-
-
Address: AVDA DE EUROPA 34 1º D (MADRID).
-
-
Featured products:
More information on TRICHOME PHARMA SL
-
15/02/2023 | BORME act no.: 80602 | Register: MADRIDAmpliación de capital
-
15/02/2023 | BORME act no.: 80602 | Register: MADRIDModificaciones estatutarias
-
24/01/2023 | BORME act no.: 38588 | Register: MADRIDAmpliación de capital
-
03/11/2022 | BORME act no.: 480858 | Register: MADRIDCambio de domicilio social
-
24/02/2022 | BORME act no.: 83276 | Register: MADRIDAmpliación de capital
-
20/08/2021 | BORME act no.: 392098 | Register: MADRIDAmpliación de capital
-
25/02/2021 | BORME act no.: 92961 | Register: MADRIDCambio de objeto social
-
05/11/2020 | BORME act no.: 379447 | Register: MADRIDConstitución
-
05/11/2020 | BORME act no.: 379447 | Register: MADRIDDeclaración de unipersonalidad
Other information
The CIF assigned to TRICHOME PHARMA SL is B02725604, and its current commercial status is active. The company is engaged in economic activities within the CNAE -. As for its SIC classification, it is -.
The company TRICHOME PHARMA SL has a team of Between 1 and 9 employees and reports annual revenues of less than 2 million euros. Registered in the Mercantile Registry of Madrid, it has a total of 1 registered positions. Its most recent announcement in the Borme was published on 15/02/2023, and the last deposit of its annual accounts corresponds to the year 2022.
To find out more contact details of TRICHOME PHARMA SL, such as telephone number, address, or website, you can consult the Company Data module.
If you want to obtain more information about TRICHOME PHARMA SL, you can review one of the available financial reports, the company's Annual Accounts, or check for any default incidents in the RAI delinquency file.
The financial, commercial, and legal information of TRICHOME PHARMA SL comes from official sources and is constantly updated.
Do you want to know more about TRICHOME PHARMA SL??
Find out more about this company by consulting these reports: